SCHEMBL9059747

SCHEMBL9059747

OCC(O)CN1CCNC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.54
▸ ATM Q13315 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ ADRA2A P08913 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ RAD52 P43351 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ BAX Q07812 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ USP2 O75604 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4400918 0.87 MAPT (0.64) MAPTATMSMN1; SMN2ADRA2AADRA2B
SCHEMBL1361161 0.87 MAPT (0.64) MAPTATMSMN1; SMN2ADRA2AADRA2B
SCHEMBL16908299 0.87 MAPT (0.64) MAPTATMSMN1; SMN2ADRA2AADRA2B
SCHEMBL10696876 0.85 MAPT (0.61) MAPTATMSMN1; SMN2ADRA2AADRA2B
SCHEMBL21757993 0.85 MAPT (0.61) MAPTATMSMN1; SMN2ADRA2AADRA2B
SCHEMBL15553304 0.85 MAPT (0.61) MAPTATMSMN1; SMN2ADRA2AADRA2B
SCHEMBL14034485 0.85 MAPT (0.61) MAPTATMSMN1; SMN2ADRA2AADRA2B
SCHEMBL9060103 0.82 SMN1; SMN2 (0.46) MAPTATMSMN1; SMN2RAD52MEN1
SCHEMBL9493787 0.80 MAPT (0.67) MAPTATMSMN1; SMN2ADRA2AADRA2B
SCHEMBL2554356 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 — — EP claimed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 — — EP claimed
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 — — WO disclosed
US-5373008-A Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents THE BOOTS COMPANT PLC. (GB) 1994-12-13 — — US disclosed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 — — EP disclosed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 — — EP disclosed
Send feedback